The histone code of senescence H Paluvai, E Di Giorgio, C Brancolini Cells 9 (2), 466, 2020 | 56 | 2020 |
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness E Di Giorgio, E Franforte, S Cefalù, S Rossi, AP Dei Tos, M Brenca, ... PLoS genetics 13 (4), e1006752, 2017 | 48 | 2017 |
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells E Di Giorgio, E Dalla, E Franforte, H Paluvai, M Minisini, M Trevisanut, ... Nucleic Acids Research 48 (2), 646-664, 2020 | 47 | 2020 |
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers E Di Giorgio, H Paluvai, E Dalla, L Ranzino, A Renzini, V Moresi, ... Genome Biology 22, 1-25, 2021 | 36 | 2021 |
Unscheduled HDAC 4 repressive activity in human fibroblasts triggers TP 53‐dependent senescence and favors cell transformation H Paluvai, E Di Giorgio, C Brancolini Molecular oncology 12 (12), 2165-2181, 2018 | 23 | 2018 |
Genetic programs driving oncogenic transformation: Lessons from in vitro models E Di Giorgio, H Paluvai, R Picco, C Brancolini International Journal of Molecular Sciences 20 (24), 6283, 2019 | 6 | 2019 |
Histone deacetylase (HDACs) inhibitors: Clinical applications KD Shanmukha, H Paluvai, SK Lomada, M Gokara, SK Kalangi Progress in Molecular Biology and Translational Science 198, 119-152, 2023 | 3 | 2023 |
HDAC4 controls senescence and aging by safeguarding the epigenetic identity and ensuring the genomic integrity E Di Giorgio, H Paluvai, E Dalla, L Ranzino, A Renzini, V Moresi, ... bioRxiv, 2020.06. 04.132787, 2020 | 1 | 2020 |
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases H Paluvai, KD Shanmukha, J Tyedmers, J Backs Frontiers in Molecular Biosciences 10, 2023 | | 2023 |
Role of HDAC4 in the process of oncogenesis in human cells H Paluvai Università degli Studi di Udine, 2020 | | 2020 |